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ABSTRACT 
Both dibutyryl cyclic AMP (DBcAMP) and cholera toxin promote the formation 
and elongation of processes of cultivated Greene hamster melanoma cells. The 
formation and maintenance of these processes, which contain many microtubules, 
are sensitive to colcemid and vinblastine. Tubulin was measured by [3H]colchicine 
binding  and  by  acrylamide gel  electrophoresis.  We  found  that  DBcAMP  or 
cholera toxin increases the ratio of polymerized to unpolymerized tubulin but not 
the total amount of tubulin per cell. The sum of the lengths of microtubules per 
unit area was significantly greater in cells treated with DBcAMP than in control 
cells.  Our findings support the hypothesis that cyclic AMP promotes the elonga- 
tion of cell  processes  by stimulating  the  assembly  of microtubules  from existing 
tubulin. 
In addition to their effect on cell  division (9, 39, 
48), cyclic adenosine 3'5'-monophosphate and its 
dibutyryl  derivative  (DBcAMP)  alter  the  mor- 
phology of many different cell types. Cyclic AMP 
induces the formation of long, narrow processes in 
mouse neuroblastoma (31, 43), Chinese hamster 
ovary cells  (CHO)  (25,  45),  and fetal  rat  brain 
cells  (46).  Mouse  sarcoma cells  become spindly 
with elongated cell bodies and long, narrow proc- 
esses (28). Microtubules apparently serve in both 
the formation and maintenance of these processes 
(10).  Microtubules are abundant in thin sections 
of neuroblastoma "neurites" (44); vinblastine sul- 
fate, a drug that forms crystalline structures with 
tubulin  (3),  inhibits  the  induction  of long  proc- 
esses in neuroblastoma cells by DBcAMP (43). 
The correlation between microtubules and cell 
processes  suggests  three  possible  mechanisms 
whereby  cyclic  AMP  causes  a  morphological 
change. (a) Cyclic AMP permits or promotes the 
reorientation  of  assembled  tubules.  (b)  Cyclic 
AMP stimulates the de novo synthesis of tubulin, 
shifting  the  equilibrium  toward  the  assembly  of 
microtubules.  (c) Cyclic AMP stimulates the  as- 
sembly of tubules  without affecting the synthesis 
of tubulin. 
We  report  here  the  effects  of cholera  toxin, 
which increases intracellular levels of cyclic AMP 
in  melanoma  cells  (2,  36),  and  of  exogenous 
DBcAMP  on  the  morphology  of  cultivated 
Greene melanoma cells. We present evidence that 
(a)  microtubules  are  involved  in  the  formation 
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esses, (b) that microtubules observed in thin sec- 
tions are significantly longer in cyclic AMP-treated 
cells than in untreated cells,  (c) that the ratio of 
polymerized to free tubulin is significantly greater 
in cells treated with cyclic AMP than in untreated 
cells,  and  (d) that cyclic AMP  does not increase 
the total amount of tubulin per cell.  We conclude 
that either DBcAMP  or cholera toxin stimulates 
process  formation by promoting  the  assembly of 
microtubules from pre-existing tubulin. These ob- 
servations have been presented previously in pre- 
liminary form (12). 
MATERIALS  AND  METHODS 
Cell Culture 
A  hamster melanoma described in  1958 by Greene 
(18)  and  maintained in  Syrian  Golden  hamsters (ob- 
tained from Dennen) was adapted to cell culture. Cells 
were grown in minimal essential medium (Grand Island 
Biological Co., Grand Island, N. Y.), with the following 
additions: 5% fetal calf serum, 2.2 mg/ml sodium bicar- 
bonate,  and  antibiotics  consisting  of  either  penicillin 
(199 U/ml) and streptomycin (100/~g/ml) or 50 p,g/ml 
gentamycin (Schering Corp., Nutley, N. J.). Cells were 
grown as a  monolayer in Falcon plastic flasks (Falcon 
Plastics, Div. of BioQuest, Oxnard, Calif.) at 37~  in a 
humidified atmosphere containing 5 % CO2. Culture me- 
dium was changed every other day. 
Colchicine Binding Assay 
Cells were  harvested in CMF-EDTA Tyrode's solu- 
tion and sedimented at 4~  All subsequent operations 
were carried out at 4~  Melanoma cells or tumor were 
washed twice in CMF-EDTA Tyrode's solution and ho- 
mogenized or sonically disrupted in 2.0 ml of SMT (0.24 
M sucrose, 0.001 M MgCl2, 0.01 M Tris, pH 7.0). The 
homogenate was examined by phase microscopy to ver- 
ify cell breakage. CaC12, final concentration 8 mM, was 
added to depolymerize tubules, and the homogenate was 
then centrifuged for 20 rain at 2,500 g. The pellet was 
stored  at  4~  and  the  supernate  was  centrifuged  at 
100,000 g  for  60  min, The  pellet from  this step was 
resuspended in SMT (+8 mM calcium) (2ml/10  s cells) 
and combined with the first pellet. 8 mM calcium did not 
influence the distribution of colchicine-binding activity in 
the supernate and pellet of the 100,000 g centrifugation. 
The  resuspended  pellet was  again sonically disrupted. 
The  100,000 g  supernate  and  the  resuspended  pellet 
were used in separate binding assays, and their protein 
concentrations were determined by the method of Lowry 
et al. (33). The colchicine-binding assay was performed 
as described by Borisy (4) in the absence and presence of 
5  ￿  10  -4 M vinblastine sulfate (Eli Lilly & Co., Indian- 
apolis, Ind.). Binding per milligram protein was deter- 
mined from decay curves of binding activity extrapolated 
to  0  incubation time  (55).  Colchicine  binding in  the 
supernate and pellets was standardized using the binding 
at 0~  as background.  [aH]colchicine  (sp act 5-16  Ci/ 
mmol) was obtained from New England Nuclear Corp., 
Boston, Mass. 
DETERMINATION  OF  RATIO  OF  UNPOLYMER- 
IZED  TO  POLYMERIZED  TUBULIN"  2.1  x  107 
cells were harvested in CMF-EDTA Tyrode's solution at 
37~  Pellets were resuspended in 0.3 ml MTS buffer 
(50% glycerol, 5% dimethyl sulfoxide, 0.5 mM EGTA, 
0.5 mM guanosine triphosphate, and 0.5 mM MgCI2 in 
10 mM sodium phosphate buffer, pH 6.95) and sonically 
disrupted at room temperature until cells were no longer 
recognizable by phase microscopy. The homogenate was 
fractionated as described in Fig.  5  (41).  The homoge- 
nized cells were centrifuged at 8,500 g, for 10 min at 
25~  and  the  supernate  (SN1)  was  kept  at  0~  The 
pellets were resuspended in 0.3 ml of TS buffer (0.25 M 
sucrose, 0,5 mM GTP, 0.5 mM MgCl2,  0.05% bovine 
serum albumin in 10 mM phosphate buffer, pH 6.95) at 
4~  and centrifuged at  8,500 g,  10  min, at  4~  The 
supernate  (SN2)  contained tubulin disassembled from 
tubules by low temperature. The final pellet was resus- 
pended (P2) in 0.3 ml of TS buffer. Colchicine binding 
activity of the SN 1, SN2, and P2 fractions was measured 
by the  method of Sherline et  al.  (49).  100 h  of each 
fraction were incubated at 30~  for 1.5 h with 10 h of 
[3H]colchicine  (1.6  x  10  -~ mg [aH]colchicine, 1  ￿  10  ~ 
cpm). 1 ml of activated charcoal (3 mg/ml distilled HzO) 
was added to each sample. After 10 min, the samples 
were centrifuged at 1,100g for l0 min. A 200 h portion 
was removed from each sample, and radioactivity was 
determined in 10 ml of Triton X-100 fluor (4). Binding 
was directly proportional to the amount of protein in the 
range of 50-400 h of homogenate for each of the frac- 
tions.  SN1  represents free tubulin, SN2 represents as- 
sembled tubulin subsequently disassembled by low tem- 
perature, and P2 represents residual tubulin in the pellet 
not solubilized by the addition of cold TS buffer. 
[3H]  Leucine Incorporation 
[3H]Leucine (sp act 33 Ci/mmol) was obtained from 
New England Nuclear Corp. Cells were cultured in me- 
dium  containing  1  ~Ci/ml  [aH]leucine for  24  h,  har- 
vested in CMF-EDTA Tyrode's solution at  37~  and 
sedimented. The pellet was resuspended in 2 ml of saline 
(4~  and an aliquot (15 X) was removed for measure- 
ment of cell number. Cells were lysed by freezing and 
thawing in distilled H20,  and protein was precipitated 
with  5%  trichloracetic  acid  (TCA).  Incorporation  of 
isotope into protein was determined by the method of 
Mans and Novelli (34)  using glass fiber filters (Reeve 
Angel glass fiber filter grade  943  AH  214  Em).  The 
filters were placed in Liquifluor, and radioactivity was 
measured in a Nuclear Chicago Spectrometer (Nuclear 
Chicago Corp., Des Haines, Ill.). 
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Cell processes were measured at 100￿  magnification 
with a calibrated ocular micrometer using a Nikon MS-D 
inverted phase-contrast microscope. 
Electron Microscopy and Estimation of 
Relative Number of Microtubules 
Cells on a plastic substratum were fixed in 3% glutar- 
aldehyde  at 37~  stained with  1%  osmium tetroxide, 
dehydrated  in ethanol,  and  embedded in  Epon.  They 
were  sectioned in a  plane parallel to  their substratum 
with an LKB  Ultrotome III equipped with a  diamond 
knife.  The  ultrathin sections were  stained with uranyl 
acetate and lead citrate and examined in a Hitachi HU- 
11 B electron microscope. 
To compare the amount of microtubules in cells ex- 
posed to DBcAMP and untreated cells, the total length 
of microtubules in prints was measured and divided by 
the total cell area observed. Tubules in the cell bodies of 
untreated cells were compared with those in the proc- 
esses of ceils treated with DBcAMP for 16 h. Total area 
was calculated by tracing the cell areas from prints of 
final magnification of 40,000 onto paper and weighing 
the paper. The measurements are presented as length of 
tubules in centimeters per square centimeter. 
Chemicals 
N6,O21-Dibutyryl  adenosine-3',5'-cyclic  monophos- 
phoric acid, adenosine 3',5'-cyclic monophosphoric acid, 
cycloheximide, Colcemid and colchicine were obtained 
from Sigma Chemical Co., St. Louis, Mo., and vinblas- 
tine sulfate (Velban) was a gift from Eli Lilly  &  Com- 
pany. Butyric acid obtained from Fisher was neutralized 
with 1N NaOH. Theophylline was obtained from Nutri- 
tional Biochemicals Corp., Cleveland, Ohio. Crude ra- 
cemized MSH was provided by Dr. Saul Lande of this 
department. 
CHOLERA TOXIN:  Purified cholera toxin lot 0572 
(Syn. choleragen, cholera exoenterotoxin, cholera enter- 
otoxin, cholera permeability factor,  PF)  was prepared 
under contract for the National Institute of Allergy and 
Infectious Diseases by R.  A.  Finkelstein,  Ph.D.,  The 
University of Texas Southwestern Medical School, Dal- 
las,  Texas  (13).  The  toxin was  dissolved in 0.152  M 
NaCI,  0.019  M  NaH2PO4,  0.081  M  NaH2PO4  at  pH 
7.15 to give a concentration of 200/~g/ml. The solution 
was  passed  through a  Millipore filter  (0.22  /zm)  and 
stored in  1-ml lots in sterile glass vials at -70~  The 
activity of the toxin was not reduced by storage under 
these conditions for at least 10 mo, nor by three cycles of 
thawing and freezing. 
Preparation of Lumicolchicine 
Lumicolchicine  and  [all]methyl lurnicolchicine were 
prepared as described by Wilson and Friedkin (56). 
Acrylamide  Gel Electrophoresis 
Protein samples were reduced in 1% sodium dodecyl 
sulfate (SDS) and 2.5% mercaptoethanol. Electrophore- 
sis was carded out on 7.5%  acrylamide gels containing 
0.1%  SDS  (2.5  ma/gel).  Gels were  stained with fast- 
green  for  quantitative  estimation of protein  (16)  and 
scanned with a Beckman gel scanner (Acta C-III Model, 
Beckman Instruments, Inc.,  Palo Alto,  Calif.) at  645 
nm.  Molecular weight  determinations of tubulin were 
carded out using standards according to the method of 
Weber  and  Osborn  (53).  Guinea  pigs'  brain  tubulin, 
isolated according to the method of Shelanski et al. (47), 
was used as a standard. 
MEASUREMENT  OF  INTRACELLULAR  CYCLIC 
AMP:  Cells  grown  on  plastic  Falcon  tissue  culture 
dishes were rinsed twice with phosphate-buffered saline 
(pH 7.4) and the protein was precipitated with 5 % TCA 
(4~  The cells were scraped off the plastic in 5% TCA 
and the suspension was sedimented at 2,000 g, 4~  for 
20 rain. Protein content of the pellets was measured by 
the method of Lowry et al. (33). The supernates were 
extracted five times with 10 ml each of ethyl ether and 
then passed through 3-cm columns of Dowex resin 1-8￿ 
(200-300 mesh) in 0.1 M formic acid. Cyclic AMP was 
eluted from the columns with 5 ml of 1 N formic acid and 
the eluates were lyophilized. Lyophilisates were resus- 
pended  in  2  ml  of  0.1  N  tris  pH  7.4.  Assays  were 
performed on these samples with a cyclic AMP-binding 
protein (provided by Dr. John Pawelek of this depart- 
ment), according to the method of Brown et al. (6). 
RESULTS 
Effects of DBcAMP on Morphology 
of Melanoma Cells 
Greene melanoma cells are polygonal and occa- 
sionally possess elongated cellular processes (Fig. 
1 a). After 24 h  of treatment with DBcAMP, the 
cells have more and longer narrow processes than 
control cells (Fig.  1 b). 
In order to quantitate this effect, DBcAMP  (1 
mM) was added  to  Greene  melanoma cells 24 h 
after plating (5  ￿  105 cells/flask),  and cells were 
examined at intervals up to 72 h. Cells with proc- 
esses projecting greater than 20/xm from the cell 
body were counted. 2-8% of a control population 
of  cells  had  processes  longer  than  20  /xm.  Re- 
sponse  to  any  treatment is expressed  as the  per- 
centage  of cells with processes  20  p.m  or longer 
above  or  below  control  level,  which  has  been 
adjusted to zero (Table I). 
Table  I  shows that, as early as 3  h  after treat- 
ment with DBcAMP  or DBcAMP  plus theophyl- 
line (Table II), there was a  significant increase in 
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(20.12%  -  4.7%). The maximum percentage was 
observed between 16 and 18 h (34.4%  --- 7.2%), 
and  the  level declined thereafter despite further 
addition of DBcAMP. 
Analogues and components of DBcAMP were 
tested for their ability to induce process formation 
in  Greene  melanoma  cells (Table II). cAMP (1 
mM) plus theophylline acted like DBcAMP; AMP 
(1  mM)  had no effect. Sodium butyrate (2 mM) 
stimulated process formation but significantly less 
so than  DBcAMP or cAMP. Theophylline (6  x 
10-4 M), an inhibitor of phosphodiesterase activ- 
ity, potentiated the effect of cAMP but was inef- 
fective alone. 
FIGURE  1  Phase-contrast  photomicrographs  of  culti- 
vated Greene melanoma cells. Cells were plated at 5.0 x 
105 cells/flask (25 cm  2 area). (a) Control cells after 24 h. 
(b) Cells exposed to DBcAMP (1 raM) and theophyUine 
(6 x  10  -4 M), 24 h. Bar represents 200/xm. 
Effect of Cholera  Toxin and MSH on 
Morphology of Greene Melanoma Cells 
Both cholera toxin (2, 36) and melanocyte stim- 
ulating  hormone  (MSH)  (36,  57)  are  known  to 
bind to the surface of Cloudman melanoma cells 
and  to  increase  intracellular  levels  of  cAMP. 
These compounds were tested for their ability to 
stimulate process formation in Greene melanoma 
cells. Table III shows that cholera toxin (1.25/~g/ 
ml)  stimulates process formation to  roughly the 
same degree as DBcAMP (1 mM) while MSH (2 
x  10 -s M) does so only after 40  h. Even at this 
time, the stimulation by MSH is only one-third of 
that of DBcAMP or cholera toxin. Cholera toxin 
causes a  10.5-fold increase in intracellular cyclic 
AMP  while MSH  stimulates only a  2.5-fold in- 
crease (Table IV) after 1 h  of exposure. 
Effect of Mitotic Inhibitors on 
Induction of Process Formation 
The role of microtubules in the formation and 
maintenance of processes in DBcAMP-treated cell 
populations was explored with the use of the alka- 
loids vinblastine sulfate, Colcemid, and colchicine. 
Greene  melanoma  cells  were  treated  with  Col- 
cemid (10  -7 M) and DBcAMP (1 raM) or vinblas- 
tine sulfate (10  -8 M) and DBcAMP (1 mM). Ta- 
ble I  shows that both vinblastine sulfate and CoP 
cemid  completely blocked  the  induction  of cell 
processes. Lumicolchicine (10  -7 M) does not pre- 
vent the induction of processes by DBcAMP. The 
stability  of  DBcAMP-induced  processes  in  the 
presence  of a  mitotic inhibitor was  also  tested. 
Cells cultivated in the  presence of DBcAMP for 
16  h  were  treated with  10 _7  M  Colcemid. Proc- 
TABLE  I 
Effect of lnhibitors of Mitosis and Protein Synthesis on Cell Process Formation 
Percent of cells with processes ->20 t~m 
Treatment  3-6 h  18 h  24 h  30 h  48 h  72 h 
DBcAMP (1  x  10  -3 M)  20.12 -+  4.7  34.4 .+ 7.2 
Cycloheximide (2  x  10  -6 M)  -1.9  .+  1.6  -7.6  .+  1.2 
DBcAMP & cyeloheximide  3.2 •  1.5  6.9 .+  3.1 
Colcemid (10  -7 M)  -6.05 .+ 2.4  -8.7  .+ 3.0 
DBcAMP &  Colcemid  -3.4  .+ 4.1  1.3 .+  0.0 
Vinblastine sulfate (10  -a M)  -8.9  .+  1.2  -7.6  +  1.0 
DBeAMP & vinblnstine  sulfate  -6.6  -  0.5  -  1.05 .+  1.0 
Lumicolchieine (10  -7 M)  1.0 .+  1.0  2.5 .+  1.9 
DBcAMP & lumicolchicine  25.5 •  5.0  39.0 •  6.0 
-4.4  •  0.9 
3.25 -+  1.0 
32 .+  13 
-8.9  -+  47  -6.2  -+  3.4 
-0.8  .+  1.6  -3.0  .+ 2.0 
-6.3  .+ 2.9  -3.1  .+ 3.1 
-0.1  .+ 2.1  0.3 .+  2.0 
0.5 •  1.0  4.1  -+  3.0 
29.1  .+ 3.1  30.0 -+  2.8 
17 -+  6.7 
Greene melanoma cells were plated at 5.0 ￿  10  s cells per flask (25 cm  z area); additions were made 24 h later. Medium was changed every other day. All cells 
exposed to cycloheximide were pretreated with this drug for 3 h. Cells with processes greater than or equal to 20/,tin were scored. Each datum represents the 
mean of five measurements. 300-500 cells were counted for each measurement. Concentrations and standard deviations are shown. Values are expressed as 
percent more or less than control, which was adjusted to 0. 
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Effect of DBcAMP Related Compounds on Process Formation 
Percent  of cells  with processes  ->20/an 
Treatment  15 h  24 h  39 h  48 h  63 h  72 h 
AMP (1 mM)  1.8 •  1.8  -0.7 •  1.5  -0.6 •  2.8  -1.2 •  1.6 
DBcAMP (1  mM) + theophylline  21.8 •  2.5  26.2 •  0.7  12.4 •  1.4  9.2 •  0.8 
(6 x 10-' M) 
Butyrate (2 raM)  5.7 •  1.7  7.3 •  1.6  6.7 4. 2.7  9.3 •  1.1 
cAMP (1 raM) + theophylline  (6 x  19.0 4- 1.6  8.6 •  1.6 
10  -4 M) 
Theophylline  (6 x 10  -4 M)  5.4 •  0.5  1.8 •  2.2 
DBcAMP  19.2 •  3.0  28.3 --- 2.0  10.5 •  2.0  8.0 •  1.ll 
cAMP  10.1 --- 1.0  4.3 •  1.0 
6.2 --- 2.1 
5.5 •  1.5 
2.0 •  0.0 
Conditions  were the same  as for Table I. 
TABLE III 
Effect of Cholera Toxin and Crude Racemized MSH on Process Formation 
Percent of cells  with  processes  ~20 ttm 
Treatment  6 h  10 h  17 h  24 h  41 h 
DBcAMP (1 mM)  12.0  ---  2.0  17.4  •  1.6  34.0 •  3.3  25.6  ~  3.1  19.6  •  1.5 
Cholera  toxin  (1.25  12.3  -+  1.5  19.6  •  3.0  34.2  -+  5.6  27.0  •  3.0  19.1  •  2.0 
/zg/mi) 
MSH (2  x  10  -s M)  2.4  -+  0.7  1.7  -+  1.0  1.7  -  0.5  5.5  •  2.1  10.5  •  1.0 
Conditions were the same as for Table I. 
TABLE IV 
Effect of Cholera Toxin and Crude Racemized MSH on Intracellular Cyclic AMP Levels 
Increase  above 
cAMP/dish  cAMP/rag protein  cAMP/10  ~  cells  control 
pmol  pmol  pmol 
Control  3.6  -+ 0.6  9.4  +  1.6  2.4  --  0.4  -- 
Theophylline (6  x  10  -4 M)  5.2  -+  0.2  13.5  -+  0.5  3.5  -+ 0.1  1.5x 
MSH (2  x  10-8 M)  9.1  -+  0.9  23.7  -  2.3  6.1  --  0.6  2.5x 
Cholera toxin (1.25  /zg/ml)  37.8  ---  2.4  98.4  -  6.3  25.2  -+  1.6  10.5x 
MSH  +  theophylline  15.0  -+  3.0  39.1  •  7.8  10.0  •  2.0  4.2x 
Cholera toxin +  theophylline  42.3  -+  8.0  110.2  -  20.8  28.2  •  5.3  ll.8x 
Intracellular cyclic AMP content after a  1-h exposure to cholera toxin (1.25/~g/ml) or to crude racemized MSH (2 x 
10  -s M). Cells were seeded into 80-mm diameter Falcon plastic tissue culture dishes (1.5  x  10  ~ cells/dish) for 24 h. 
Cholera toxin or MSH was then added for 1 h, the medium was poured off, and cyclic AMP assays were performed. 
esses  disappeared  within  1  h,  and  the  cells ac- 
quired a  polygonal morphology, despite the con- 
tinued presence of DBcAMP (Table V).  10 -r M 
colchicine had the same effect. These results sug- 
gest that microtubules are necessary for both the 
formation  and  maintenance  of  processes  in 
Greene melanoma cells. 
Effect of Inhib  ito rs of Protein 
Synthesis on D BcAMP-Induced 
Process Formation 
In  order to  learn whether  protein synthesis is 
necessary for the induction of long cell processes 
by  DBcAMP,  cycloheximide was  added  to  the 
cultures.  Incorporation  of  [3H]leucine  was  in- 
hibited by  exposure  to  cycloheximide (2  x  10  -0 
M) for 24 h, regardless of the presence or absence 
of DBcAMP  (Table  VI).  Table  I  shows that,  in 
the  presence  of  cycloheximide,  DBcAMP  in- 
creased  process  formation  to  only  6.9  -+  3.1% 
above the control level after 24 h; cycloheximide 
alone  reduced  it  to  7.6  -  1.2%  below  control 
level.  The  difference  between  cells  exposed  to 
cycloheximide  alone  and  cells  exposed  to  both 
cycloheximide and  DBcAMP  at  what  is  usually 
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Effect  of  Colcemid on DBcAMP-Induced Processes 
Treatment 
Percent of cells with processes  ->20 ,~m 
Time after addition  of Colcemid 
Oh  lh  5h  10h 
DBeAMP (1  mM)  +  theophylline (6 
x  10 -4 M) 
Coleemid  (10 -7  M)  +  DBcAMP  (1 
mM) + theophylline (6 ￿  10  -4 M) 
27.2  --- 3.3  21.6  --- 1.5  27.8  +- 3.2  29.5  --- 5.4 
27.2  _+ 3.3  8.2 +- 1.8  5.8  +_  1.0  5.4  _+  1.1 
Conditions were the same as for Table I. 24 h after seeding, flasks were treated with 1 mM DBcAMP and 6 ￿  10-4 M 
theophylline. After 16 h, the medium was changed, and 10 -7 M Colcemid was added to half the flasks. 
TABLE  VI 
[aH]Leucine Incorporation  into  TCA-Insoluble 
Protein 
Incorporation 
Additions to medium  clam/10  a ceils  Inhibition 
% 
None  178  -+ 31  - 
DBcAMP (l  mM)  +  theo-  190  _+ 34.4  -9.3 
phytline  (6 x  10 -'t M) 
Cycloheximide  (2  x  10 -6  22.9  -+ 0.8  88 
M) 
DBcAMP (1  mM)  +  theo-  24  _+ 0.03  88 
phyline (6  ￿  10 -4 M)  q- 
cycloheximide (2  x  10 -6 
M) 
Cells  were plated at  5  x  105 per flask  (25  cm  2 area). 
After 24 h, appropriate flasks received a 3-h exposure to 
2 x  10 -6 M cycloheximide. 3 h later, fresh medium with 
the  indicated  additions  was added.  The  medium  con- 
tained  1 /zc/ml [aH]leucine.  After 24 h, cells were re- 
moved from culture flasks  with CMF-EDTA Tyrode's 
solution and counted in a haemocytometer. Pellets were 
assayed  for  [3H]leucine  incorporation according to the 
method of Mans and Novelli (34). Each value represents 
the mean of two flasks. 
the time of maximum process formation is signifi- 
cant (t  =  8.9803, df =  8). 
There was no significant difference in the rate of 
protein synthesis between control and DBcAMP- 
treated cells during the 24-h period when process 
formation reached a maximum; however, after 48 
h, DBcAMP-treated cells incorporate  60%  more 
[3H]leucine  per  cell  than  control  cells,  probably 
because  DBcAMP arrests cell division. 
Estimation of Amounts of Microtubules 
by Electron Microscopy 
Large  numbers  of microtubules  were  revealed 
in  processes  induced  by  a  16-h  exposure  to 
DBcAMP (Fig.  2).  In contrast,  tubules were far 
less abundant  in the cytoplasm of untreated cells. 
The average total length of tubules per unit area in 
thin sections of untreated Greene melanoma cells 
was only 47.2%  of that  observed in cells treated 
for 16 h  with DBcAMP (processes of DBcAMP- 
treated  cells  vs.  cell  bodies  of  untreated  cells). 
DBcAMP-treated and untreated cells had  19.5  - 
14.7  and  9.2  +-  6.3  cm  of  tubules  per  square 
centimeter, respectively. The difference is signifi- 
cant at the 0.05  level (t =  3.39069, df =  74). 
Measurement of Total Tubulin 
COLCHIEINE  BINDING  ASSAY:  In  order to 
determine  the  amount  of colchicine-binding pro- 
tein  per  cell  or  per  mg  of  cellular  protein  in 
DBcAMP-treated and control cultures of Greene 
melanoma cells, the  quantitative colchicine bind- 
ing assay  of Borisy  (4)  was used.  The  technique 
depends  on:  (a) the specific affinity of colchicine 
for tubulin,  and  (b)  the strong adsorption  of mi- 
crotubular  protein  to  DEAE  ion  exchangers  at 
neutral pH. 
The  validity of the  binding  measurements  was 
tested by the following controls.  (a) The binding 
of colchicine to  bovine  serum  albumin  or to  the 
100,000g supernate heated to 70~  for 20 rain, or 
incubated at 0~  rather than 37~  was not signifi- 
cantly greater than background  (incubation in the 
absence  of  protein).  (b)  Binding  activity  of 
[aH]lumicolchicine  was  only  5%  that  of 
[aH]colchicine and did not increase with increasing 
amounts  of  protein.  (c)  The  amount  of  bound 
colchicine was directly proportional to the amount 
of cellular protein  in the reaction mixture over a 
range  of  0.1-1.5  mg  protein.  Accordingly,  this 
range  of  protein  concentration  was  used  in  the 
measurement of the amount of colchicine-binding 
protein from decay curves. 
740  TuE  JOURNAL  OF  CELL  BIOLOGY '  VOLUME  71,  1976 FmURE  2  Electron micrographs  of (a)  DBcAMP-treated (1  raM,  16  h) and  (b) untreated  Greene 
melanoma cells. Note that the cell bodies of untreated cells have microtubules (arrows) but the tubules are 
more abundant and longer in the cell processes of DBcAMP treated cells. Bar represents  2.5 p.m. 
To compare the  specific colchicine-binding ac- 
tivity of DBcAMP-treated, cholera toxin-treated, 
and untreated cells, it was necessary to determine 
the  decay rates of colchicine binding and  to  ex- 
trapolate  to  zero  incubation  time  (55).  Fig.  3 
shows  the  decay  rates  for  these  various  treat- 
ments.  It is clear in  all cases that  (a)  the  decay 
rates in treated and untreated cells are similar in 
both the pellets and the  supernates,  (b) vinblas- 
tine  significantly  stabilizes  the  binding  activity 
(55),  and  (c) extrapolation to  0  incubation time 
gives similar specific binding activities. The  spe- 
cific binding activity per cell of DBcAMP-treated 
and cholera-toxin treated ceils at the time of maxi- 
mal process formation is, respectively, 100% and 
90%  that of control cells (Table VII). 
The  solid Greene  tumor  has  significantly less 
binding activity (3,400 -  200 cpm/mg protein and 
1,800 -+ 400 cpm/mg protein in the supernate and 
pellet,  respectively) than  both  the  mouse  brain 
DIPASQUALE ET  AL.  Microtubule Assembly in Cultivated Melanoma Cells  741 8ts 
.] 
o 
￿9  x 
4- 
I  0  2- 
x 
:E 
13. 
U  O  !  I,  I  I 
ta  P 
Z 
z 
-r 
B 
0 
',r 
-1.5  0  1 
PRE INCUBATION (H) 
FmURE  3  Colchicine  binding decay curves of colcl~- 
cine  binding  protein from  untreated  (x)  and  cholera 
toxin-treated (￿9  cells. S represents 100,000g supernate, 
P pellet. All samples were incubated with [3H]colchicine 
for 1.5 h; only the time of incubation at 30"C before the 
addition  of  [3H]colchicine (preincubation)  varied. 
Curves  for protein from  cells treated with  DBcAMP 
(10 -3  M)  were  similar  to  those  of cells treated with 
cholera  toxin  but  are  eliminated  from  the  figure  for 
clarity. Samples contained the following amounts of pro- 
tein: cholera toxin-treated  cells (S = 0.965 mg/150 h, P 
= 0.481  mg/150 h); untreated cells (S =  0.975 mg/150 
h,  P  =  0.469  mg/150  h).  Curves  denoted  by  +v 
represent decay in the presence of 5 ￿  10  -4 M vinblas- 
tine sulfate. 
(390,000 -  1,500 cpm/mg protein and 201,000 • 
1,000 cpm/mg protein in the supernate and pellet, 
respectively)  and  the  cultivated  unstimulated 
Greene melanoma cells. 
ACRYLAMIDE  GEL  ELECTROPHORESIS  : 
Densitometric  scans  of  SDS-acrylamide gels  of 
the  100,000  g  supernate  of  Greene  melanoma 
cells (Fig. 4) show a tubulin band at 55,000 tool wt 
in  cholera  toxin-treated and  untreated  samples. 
This  protein  coelectrophoreses  with  guinea  pig 
brain tubulin. Integrated optical densities at 645 
nm obtained from gel scans were directly propor- 
tional to the amount of tubulin over a concentra- 
tion  range  of  2-40  /zg  tubulin  per  gel.  The 
[3H]colchicine-binding data  (Table  VIII)  shows 
that the amount of tubulin (in the soluble protein 
fraction) per cell is roughly the same in both chol- 
era  toxin-treated  (16  h)  and  untreated  Greene 
melanoma  cells  (roughly  10.4  /zg/106  cells  for 
controls;  10.5  /~g/10  ~  cells  for  cholera  toxin- 
treated cells). Also, the colchicine-binding activity 
of the tubulin in the soluble protein fraction is not 
altered  by  cholera  toxin-treatment  for  16  h 
(roughly 1,154 cpm//zg tubulin for controls; 1,066 
cpm/p,g  tubulin  for  cholera  toxin-treated cells). 
Similar results were obtained with DBcAMP. 
It is  possible that  some  of the  protein in  the 
55,000  mol  wt  band  is not tubulin.  This would 
invalidate  any  calculation of the  specific colchi- 
cine-binding activity of tubulin in treated and un- 
treated cells. Two considerations justify our esti- 
mates:  first, our estimates of specific colchicine- 
binding activity (cpm//xg tubulin) agree well with 
those estimated by others (37) using purified neu- 
roblastoma or porcine brain tubulin, second, the 
ratio of the heights of the 55,000 mol wt band of 
the  treated  and  untreated  cells with  respect to 
other major bands on the gels is remarkably simi- 
lar. If DBcAMP effected changes in the amount of 
tubulin, there would have to be a reciprocal drop 
in the nontubulin 55,000  mol wt protein for the 
total amount of 55,000  mol wt protein to be the 
same. This is improbable. 
Measurement of the Ratio of 
Unpolymerized  to Polymerized 
Tubulin 
A  buffer  containing glycerol and  DMSO  was 
used to stabilize existing microtubules so that they 
could be separated from free tubulin by centrifu- 
gation (41). Using the colchicine-binding assay of 
Sherline et al. (49), the ratio of assembled to free 
tubulin  was  determined  in  cholera toxin-treated 
and untreated cells (Table IX, Fig. 5). Consistent 
with our ultrastructural observations, the amount 
of assembled tubulin is significantly greater in cells 
treated with cholera toxin. 
The ratio of assembled to free tubulin must be 
accepted  with  reservations.  Ideally,  the  cells 
should be sonicated at 37~  to avoid depolymeri- 
zation of tubules.  No  colchicine-binding activity 
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Specific Binding Activity of DBcAMP- Treated and Cholera-Toxin Treated Cells 
mg protein/10  ~  Median cell 
Treatment  Fraction  cells  volume  cpm/mg protein  cpm/10  e cells 
Control  Supernate  0.1480  1,300  71,432  10,572 
Pellet  0.1043  28,916  3,016 
Cholera  toxin  1  /.~g/ml,  Supernate  0.1500  1,415  64,280  9,642 
16 h  Pellet  0.1090  23,900  2,600 
DBcAMP 1 mM, 16 h  Supernate  0.1520  1,420  68,300  10,382 
Pellet  0.1085  26,500  2,875 
[3H]Colchicine binding cpm/mg protein was obtained by extrapolation to zero incubation time using the decay curves 
shown in Fig. 3. 
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FIGURE  4  Densitometric scans (645 nm) of fast green- 
stained  SDS  acrylamide  gels. 'Greene  melanoma  cells 
were  cultured  with  and  without  1.25  /xg/ml  cholera 
toxin.  The  100,000  g  supernates  of  the  cells  were 
brought to 1% in SDS and 2.5% in mercaptoethanol and 
applied to gels. When samples were heated to 50~  for 
15 min before application to the gels, two bands rather 
than one were seen at the 55,000 mol wt weight region. 
(--)  66/zg of protein from control cells; (--) 55/zg of 
protein from cells exposed to cholera toxin; ( .... )  2.8 
/~g of tubulin from guinea pig brain. Molecular weights 
were determined from gels of standards of known molec- 
ular weight. 
was found in cells sonicated at 37~  so 25~  was 
chosen.  Because  lower  temperatures  reduce  the 
stability of tubules, the difference in the percent- 
age of free tubulin  between cholera toxin-treated 
and untreated cells obtained at 25~  is probably a 
minimum.  In  fact,  when  cells  were  sonicated  at 
0~  in MTS buffer, the percentages of free tubulin 
in cholera toxin-treated and  untreated  cells were 
37%  and 47%  respectively, as compared to 26% 
and 41%,  respectively, at 25~ 
DISCUSSION 
Role of Cyclic AMP  in Process Formation 
Cyclic AMP  induces the formation of long, nar- 
row  processes  in  cultivated  Greene  melanoma 
cells. This conclusion is supported by several ob- 
servations. First, experiments with compounds re- 
TABLE VIII 
Colchicine Binding Data and Acrylamide Gel 
Electrophoresis Data from a Single Experiment 
Cholera tc~in 
Control  ( 16 h) 
No of cells equivalent  to 10 ~. of  0.720  x 10  e  0.696 x 10  ￿9 
100,000g supernate 
Median cell volume  1,415/~m  a  1,550 ,o.m  s 
/ag soluble  protein/10  ~  cells  139.0  143.7 
/ag protein/10  k of 100,000g su-  100.1  100.0 
pemate 
[SH]colchicine binding cpm/101  12,000  -+ 840  11,200  -+ 180 
cells 
[SH]culehicine binding (cprn/mg  86,300  -  840  77,900  -+ 180 
soluble protein) 
txg protein  applied to gel  66.0  55.0 
Estimated /~g protein  as tubulin  4.95  4.01 
(determined from standard 
curve of fast green-stained  tu- 
bulin) 
/zg  tubulin in  soluble protein  10.4  10.5 
fraction/106 cells 
Percent of tubulin in 100,000 ￿  7.5  7.3 
g supernate 
[aH]eolehicine binding epm/#g  1,154  1,066 
tubulin 
Quantitation of tubulin by [SH]colchiclne  binding and from SDS acrylamide 
gel electrophoresis obtained on the same sample (see Fig. 4).  Amount of 
tubulin on gels was estimated from a standard curve of absorbaney at 645 am 
vs. known quantities of fast-green-stained tubulin. 
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Ratio of Assembled to Free Tubulin in Cholera  Toxin-Treated and Untreated  Cells 
Combined length of proceses 
per 100 cells (~,m) measured 
at 16h 
[SH]colchicine  bound 
SN1  SN2  P2  (SN2)t(SN1)  Total 
epm/lO ~ cells 
Cholera toxin  1,120 _+ 445  2,177  5,924  238  2.26  8,339 
Control  450 _+ 270  3,420  4,680  161  1.36  8,261 
Cells were seeded 24 h before the start of the experiment at 2 ￿  106 cells/75 cm  2  flask. At zero time, cholera toxin (1 
tzg/mi) was added to one set of flasks, and, at 16 h, the combined lengths of all the cell processes were determined in 
both cholera toxin-treated and untreated flasks. 1,500 cells in each group were counted; the processes were measured 
from distal tip to the nearest edge of the nucleus. Cells were then removed from the flasks with CMF-EDTA-Tyrode's 
solution (37~  An aliquot was taken to  measure cell numbers, and the cell suspension was centrifuged. The 
sedimented ceils were resuspended in MTS buffer, and the  [aH]colchicine binding of the various fractions was 
measured as described in Materials and Methods. 
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FIGURF 5  Flow diagram for  estimation of  free and 
assembled tubulin in undisrupted cells. Homogenized 
cells in MTS buffer (upper left comer) were centrifuged 
at 8,500 g,  10 min, 25~  Unassembled tubulin (open 
circles) remained in the  supernate  (SN1). Assembled 
tubulin  (black circles) was  sedimented (P1).  P1  was 
resuspended in TS buffer at 4~  and centrifuged at 8,500 
g,  10  min, 4~  Disassembled tubulin  (open  circles) 
remained in the supernate (SN2). The pellet from this 
centrifugation (P2), containing residual tubulin, was re- 
suspended in TS buffer. This suspension, as well as SN1 
and SN2, were assayed for colchicine-binding  activity. 
lated to DBcAMP suggest that process formation 
is caused primarily by cyclic AMP. The relatively 
low  levels  of  cyclic  AMP  that  accumulate  in 
Greene melanoma cells  exposed to  theophylline 
(Table IV) suggest a low basal adenylate cyclase 
activity and are probably not sufficient to induce 
process formation. The butyrate moiety stimulates 
process formation but significantly  less than either 
DBcAMP or 3',5'-cAMP. Although Prasad  and 
Hsie (43) found that  1 mM sodium butyrate did 
not induce neurite formation in cultured neuro- 
blastoma, Wright (58) reported that sodium bu- 
tyrate, like DBcAMP, slowed the growth rate of 
CHO cells and caused them to become more spin- 
dly. But this morphological effect was noticeable 
only after 3 days, whereas the effect of DBcAMP 
was maximal after  1 day.  Second, cholera toxin 
stimulated  process  formation  in  Greene  mela- 
noma cells. The toxin is known to bind to recep- 
tors on the cell surface, stimulating adenylate cy- 
clase  and  increasing  levels  of  cyclic  AMP  in 
Greene  melanoma  cells  (Table  IV).  Cholera 
toxin,  unlike  DBcAMP,  does  not  produce  the 
multiplicity of N6-substituted adenines (26,  38) 
that  could  perhaps  influence process  formation 
(29).  Although DBcAMP yields a  variety of re- 
lated compounds in CHO cells, it also results in 
increased concentrations of cAMP (26,  38). Ex- 
posure to cholera toxin results in an increase in 
intraceilular cAMP within 1 h.  When Cloudman 
melanoma is exposed to MSH, cAMP is maximal 
at  30  min  and  then  falls  in  spite  of  the  con- 
tinued presence of MSH. The increase in tyrosin- 
ase  activity resulting from  MSH  does not occur 
until several hours  after  the  major elevation of 
cAMP  (40).  It may also be the  case  in Greene 
melanoma that  the  morphologic changes  occur 
later than the highest cAMP concentration; how- 
ever, the time-course of cAMP stimulation has not 
been measured. 
MSH,  which  mimics  the  effects  of  dibutyryl 
cyclic  AMP  in Cloudman melanoma, is  a  poor 
stimulator of process formation in Greene mela- 
noma cells. This observation is consistent with the 
observation that the hormone does not raise intra- 
cellular  cyclic  AMP  as  much  as  cholera  toxin. 
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has  found  that,  although  I~'~I-MSH binds  to 
Greene  melanoma  cells  in  culture,  the  binding 
cannot be blocked by increasing concentrations of 
unlabeled MSH. Thus, either the MSH binding is 
not specific or there are so few specific sites that 
they  are  undetectable.  These  considerations  are 
consistent with the conclusion obtained from stud- 
ies  of Cloudman  melanoma  cells-namely,  that 
cholera toxin and MSH do not bind to the same 
receptors. Neither [~2'~I]MSH  (36) nor fluorescein- 
labeled MSH (Varga, DiPasquale, and McGuire, 
unpublished  results)  binding to Cloudman mela- 
noma cells is inhibited by high concentrations of 
cholera toxin. 
Role of Microtubules in Cell 
Process Formation 
Microtubules are cytoskeletal elements believed 
to maintain cellular configuration in vitro and in 
vivo  (7,  14,  17,  30,  51,  52,  59).  Our  results 
support this conclusion and suggest that microtu- 
bules  are  necessary for both  the  formation  and 
maintenance  of processes  in  Greene  melanoma 
cells in  vitro.  The formation and maintenance of 
these  processes  are  sensitive  to  tubulin-binding 
compounds and  insensitive  to lumicolchicine.  In 
thin  sections  of long, narrow  DBcAMP-induced 
processes  of  Greene  melanoma  cells  there  are 
numerous  microtubules  oriented  parallel  to  the 
axis of the cell processes. 
The induction of cell processes by DBcAMP is 
reduced by cycloheximide (see also reference 28). 
This  does  not  mean  that  process  formation  re- 
quires the de novo synthesis of tubulin. The for- 
mation of cell processes may require the addition 
of new surface material at the leading edge (1, 11, 
20, 22, 27) and adhesion to the substratum (8, 21, 
23) as well as microtubules. If the ability of a cell 
to insert new surface material at the leading edge 
and to adhere to the substratum depend on contin- 
ued  protein  synthesis,  then  the  extension  of the 
process  would be  restricted  despite  an  adequate 
supply of pre-existing tubulin. 
Role of Cyclic AMP in Assembly 
of Microtubules 
Of the  three  postulated  mechanisms whereby 
cyclic AMP effects a morphological change in cul- 
tivated Greene melanoma cells, our results favor a 
stimulation  of  microtubule  assembly.  Microtu- 
bules  are  more  abundant  in  cells  exposed  to 
DBcAMP.  Similar  results  with  Chinese  hamster 
ovary cells  have  been  reported  (5,  42).  Coichi- 
cine-binding  activity  per  cell  and  per  milligram 
protein  in  both  DBcAMP-  and  cholera  toxin- 
treated cells is not significantly different from that 
in untreated cells, even at a time when in treated 
cells there is a significant increase in the number of 
cell processes 20 p.m or longer. Finally, the ratio 
of assembled  to free  tubulin  in  cells  exposed  to 
cholera toxin  is significantly greater than  that in 
untreated  cells.  We  conclude  that  cyclic  AMP 
stimulates the assembly of microtubules from ex- 
isting  tubulin. 
Other workers have reported  that the amount 
of tubulin  in polygonal and  dendritic  cells  is the 
same. Mouse neuroblastoma cells are polygonal at 
optimal growth conditions but extend long proc- 
esses when deprived of serum. Despite this change 
in  shape,  the  amount  of tubulin  per  cell  is  un- 
changed  (35).  Hier  et  al.  (24)  found  that 
DBcAMP stimulates  process  formation  in  chick 
embryo sensory ganglia without increasing the col- 
chicine-binding  activity  per  ganglion;  however, 
this  observation  was  not  verified  by  measuring 
decay rates of colchicine binding in the presence 
and absence of DBcAMP. 
Two possible mechanisms through which cAMP 
might influence tubule assembly are: (a) the stim- 
ulation of a protein kinase with subsequent phos- 
phorylation  of a  factor that  promotes  assembly; 
(b) reduction of calcium concentration in the cyto- 
sol  with  corresponding  increase  in  assembly. 
Greengard and Kuo (19) and Goodman et al. (15) 
have shown that cyclic AMP in  cell-free systems 
activates a protein kinase, which in turn phospho- 
rylates serine residues in microtubular protein. Li 
et  al.  (32)  have  shown  an  in  vivo activation  of 
protein  kinase  activity in  Chinese hamster ovary 
cells  by  DBcAMP.  Phosphorylation  might  en- 
hance the  affinity of tubulin  monomers for each 
other and thus shift the equilibrium toward assem- 
bly.  More  recently,  Sloboda et al.  (50)  showed 
that, in an in vivo system, cyclic AMP stimulates 
the  phosphorylation of a  high  molecular weight 
protein  that  co-purified  with  tubulin.  However, 
this phosphorylation was apparently unnecessary 
for in vitro assembly, since tubules  assembled in 
the absence of the high molecular weight protein. 
DBcAMP might exert  its  effect on assembly by 
altering membrane permeability to calcium or the 
cell  membrane's capacity to bind calcium. Micro- 
tubules  are  unstable  in  calcium-containing solu- 
tions (54). If cAMP reduced intracellular calcium 
DIPASQUALE El"  AL.  Microtubule  Assembly in Cultivated Melanoma Cells  745 levels by altering the membrane's permeability to 
calcium or capacity to bind calcium, then it might 
stimulate the assembly of microtubules. 
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